Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
Feb 15 (Reuters) - European stocks pulled back some of their recent losses on Tuesday following reports that some Russian troops near Ukraine were returning to their bases, while some positive corporate updates also boosted sentiment.
Read moreFeb 15 (Reuters) - British stocks rose on Tuesday as global risk sentiment improved after reports that Moscow was withdrawing some troops near Ukraine calmed fears of a potential Russian invasion, while positive data from AstraZeneca and strong earnings from mining company Glencore further lifted sentiment.
Read more
(Alliance News) - Stocks in London ended higher on Tuesday after Russia adopted a more conciliatory tone in the Ukraine crisis in what could be the first major step towards de-escalation after weeks of tensions.
Read moreLONDON, Feb 15 (Reuters) - Long COVID is less likely to affect vaccinated people than unvaccinated people, a new review of 15 studies by the UK Health Security Agency released on Tuesday has concluded.
Read more
(Sharecast News) - Pharmaceutical company AstraZeneca said on Tuesday that results from a recent study revealed that its Lynparza asset reduced the risk of first-line metastatic castration-resistant prostate cancer progression by 34% when used in combination with abiraterone.
Read more(Alliance News) - AstraZeneca PLC and Merck & Co Inc on Monday reported positive trial results for Lynparza in combination with abiraterone in patients with prostate cancer.
Read moreLONDON BROKER RATINGS: DZ Bank ups Astra to hold; Jefferies ups Smiths
Read moreUncertainty ahead for AstraZeneca despite robust 2021 results
Read moreLONDON MARKET CLOSE: FTSE climbs but New York weaker after hot US CPI
Read moreLONDON MARKET MIDDAY: Markets brace for hot US inflation print
Read moreFRANKFURT, Feb 10 (Reuters) - Astrazeneca said global interest in government purchase agreements for its COVID-19 vaccine was driven by strong demand in Latin America, the Middle East and Asia, even as aggregate global demand this year will fall....
Read more(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Unilever drops as it flags inflation hit* AstraZeneca forecasts higher 2022 sales* UK house prices growth hits new six-month high in Januar...
Read more* Siemens marks best day in 13 months* German DAX index supported by strong results* AstraZeneca up on strong sales forecast (Updates to market close)By Shreyashi Sanyal and Ambar WarrickFeb 10 (Reuters) - European shares ended slightly lower on Th...
Read moreLONDON MARKET OPEN: Informa and Relx top-and-tail FTSE 100
Read moreTOP NEWS: AstraZeneca sales bolstered by Covid vaccine in 2021
Read more
Last checked at